|
Index of reports
> Cases with Septic Shock ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mylotarg (Gemtuzumab Ozogamicin) where reactions include septic shock. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mylotarg side effects in 65 year old
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-13
Patient: 65 year old
Reactions: Septic Shock
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Mylotarg
Dosage: 3 mg/m2 on days 1, 4, and 7
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 200 mg/m2 for 7 days
Indication: Acute Myeloid Leukaemia
Daunorubicin HCL
Dosage: 60 mg/m2 for 3 days
Indication: Acute Myeloid Leukaemia
|
